Tradestie Institutional Equity Comparison Engine

MBOT vs MYO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MYO Overall Edge

MYO Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Myomo Inc. (MYO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MBOT counters with relative strength in Valuation. Fundamentally, MBOT trades at 31.8x Forward P/E with -5057.2% operating margin (+0.0% YoY revenue) versus MYO at N/M Forward P/E and -21.8% operating margin (+22.2% YoY). In options structure, MBOT sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro) against MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MBOT
MBOT 31.8x vs MYO N/M Fwd P/E
Growth & Margin Winner MYO
Op Margin -5057.2% vs -21.8% ยท YoY +0.0% vs +22.2%
Momentum & Technical Winner MYO
1Y -64.6% vs +12.3% ยท 52W Pos 7% vs 16%
Options & Structure Winner MYO
BREAKDOWN (30th %ile IV) vs UNCLASSIFIED (81st %ile IV)
MBOT NASDAQ
Microbot Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.68
-8.52% 1D
Market Cap $49.9M
1M Return -27.81%
1Y Return -64.58%
Forward P/E 31.8x
Unified AI Score
54.9 / 100 HOLD
Tech 48.0 Fund 55.0 Flow 68.0 Mom 49.0
MYO NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap $33.7M
1M Return -33.52%
1Y Return +12.3%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 43.0 Flow 58.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MBOT -64.58% MYO +12.3% Spread: +76.88 pp (MYO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MBOT Revenue MYO Revenue MBOT Op. Margin MYO Op. Margin Margin Edge
FY2018 N/A $0M N/A -430.8% MYO
FY2019 N/A $0M N/A -281.3% MYO
FY2020 N/A $10M N/A -138.5% MYO
FY2021 N/A $10M N/A -74.1% MYO
FY2022 N/A $20M N/A -68.6% MYO
FY2023 N/A $20M N/A -42.8% MYO
FY2024 N/A $30M N/A -19.1% MYO
FY2025 N/A $40M N/A -35.2% MYO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MBOT (6) vs MYO (4)
Institutional Metric MBOT MYO Criterion Row Winner
Market Capitalization Scale $49.9M $33.7M Larger Scale MBOT
Trailing P/E Ratio Valuation 31.8x N/M Lower Multiple MBOT
Forward P/E Ratio Valuation 31.8x N/M Lower Multiple MBOT
Revenue Growth (YoY) Growth +0.0% +22.2% Higher Growth MYO
Operating Margin (TTM) Profitability -5057.2% -21.8% Higher Margin MYO
Net Profit Margin Profitability 0.0% -33.1% Higher Margin MBOT
Return on Equity (ROE) Capital Efficiency -26.3% -173.5% Higher ROE MBOT
52-Week Range Position Momentum 7% ($1โ€“$3) 16% ($1โ€“$2) Stronger Trend MYO
Beta / 30D Volatility Risk Regime 1.68ฮฒ ยท 145% Vol 2.22ฮฒ ยท 107% Vol Lower Realized Risk MYO
Unified Institutional Score Composite Signal 54.9 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite MBOT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MBOT vs MYO Buy Guide
MBOT BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MBOT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 81st %ile
IV Regime Extreme (>80th %ile)
Live MYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MBOT nor MYO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.